Clinical Trial Update: Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin [Phase 1]

View source ↗

Summary

Phase 1 study assessing the effects of vancomycin on gastrointestinal microbiota in patients with Primary Sclerosing Cholangitis and Biliary Atresia; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia
• Sclerosing Cholangitis

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Stanford University | Conditions: Primary Sclerosing Cholangitis, Biliary Atresia | Phase 1 | Status: COMPLETED | Results posted: 2016-03-04